As Microsoft (MSFT) Stock Rose, Schwerin Boyle Capital Management Trimmed Holding; Aerie Pharmaceuticals (AERI) Holder Suffolk Capital Management Upped Position

October 12, 2017 - By Migdalia James

Schwerin Boyle Capital Management Inc decreased its stake in Microsoft (MSFT) by 56.54% based on its latest 2017Q2 regulatory filing with the SEC. Schwerin Boyle Capital Management Inc sold 139,900 shares as the company’s stock rose 4.75% with the market. The hedge fund held 107,520 shares of the prepackaged software company at the end of 2017Q2, valued at $7.41 million, down from 247,420 at the end of the previous reported quarter. Schwerin Boyle Capital Management Inc who had been investing in Microsoft for a number of months, seems to be less bullish one the $593.80 billion market cap company. The stock rose 0.88% or $0.68 reaching $77.1. About 3.76M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 34.52% since October 12, 2016 and is uptrending. It has outperformed by 17.82% the S&P500.




Suffolk Capital Management Llc increased its stake in Aerie Pharmaceuticals Inc. (AERI) by 753.29% based on its latest 2017Q2 regulatory filing with the SEC. Suffolk Capital Management Llc bought 128,760 shares as the company’s stock declined 8.47% while stock markets rallied. The institutional investor held 145,853 shares of the health care company at the end of 2017Q2, valued at $7.67M, up from 17,093 at the end of the previous reported quarter. Suffolk Capital Management Llc who had been investing in Aerie Pharmaceuticals Inc. for a number of months, seems to be bullish on the $2.31 billion market cap company. The stock declined 1.24% or $0.8 reaching $63.5 on the news. About 309,473 shares traded. Aerie Pharmaceuticals Inc (NASDAQ:AERI) has risen 180.20% since October 12, 2016 and is uptrending. It has outperformed by 163.50% the S&P500.

Among 13 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 37 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, September 22, the company rating was maintained by JMP Securities. RBC Capital Markets maintained it with “Outperform” rating and $50 target in Wednesday, November 4 report. The firm earned “Buy” rating on Thursday, October 5 by Cowen & Co. Needham maintained the shares of AERI in report on Thursday, September 15 with “Buy” rating. Canaccord Genuity maintained Aerie Pharmaceuticals Inc (NASDAQ:AERI) on Wednesday, August 16 with “Buy” rating. The stock has “Buy” rating by Cowen & Co on Wednesday, August 2. As per Friday, September 15, the company rating was maintained by Needham. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, September 17. Canaccord Genuity maintained it with “Buy” rating and $6500 target in Tuesday, August 1 report. The company was initiated on Friday, February 17 by TH Capital.

Since May 9, 2017, it had 1 buying transaction, and 1 insider sale for $1.08 million activity. Cagle Gerald D. had bought 1,000 shares worth $39,900 on Tuesday, May 9.

Investors sentiment increased to 1.17 in Q2 2017. Its up 0.21, from 0.96 in 2017Q1. It improved, as 21 investors sold AERI shares while 48 reduced holdings. 33 funds opened positions while 48 raised stakes. 31.61 million shares or 3.55% more from 30.53 million shares in 2017Q1 were reported. Manchester Capital Management Ltd Com reported 150 shares stake. The New York-based Mufg Americas Corporation has invested 0% in Aerie Pharmaceuticals Inc (NASDAQ:AERI). Comml Bank Of Montreal Can holds 513 shares or 0% of its portfolio. State Board Of Administration Of Florida Retirement has 16,258 shares. Alps Advsrs Incorporated holds 31,934 shares or 0.01% of its portfolio. Tudor Invest Et Al accumulated 0.02% or 9,561 shares. Moreover, Rice Hall James & Assocs Ltd Liability Corp has 0.56% invested in Aerie Pharmaceuticals Inc (NASDAQ:AERI) for 244,795 shares. Prudential has 0.01% invested in Aerie Pharmaceuticals Inc (NASDAQ:AERI). The Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Aerie Pharmaceuticals Inc (NASDAQ:AERI). Capital Advisers Limited Co reported 5,500 shares. Thrivent For Lutherans reported 95,980 shares or 0.02% of all its holdings. Hightower Llc has 4,909 shares. Parametric Assoc Limited Liability Company invested in 73,623 shares. Art Ltd Liability holds 0.04% or 13,400 shares. Schwab Charles Invest Mgmt Incorporated owns 0.01% invested in Aerie Pharmaceuticals Inc (NASDAQ:AERI) for 138,289 shares.

More notable recent Aerie Pharmaceuticals Inc (NASDAQ:AERI) news were published by: Seekingalpha.com which released: “Biotech Analysis Central: Daily Pharma News – October 12, 2017” on October 12, 2017, also Nasdaq.com with their article: “Aerie Pharmaceuticals (AERI) Surges: Stock Moves 16.2% Higher” published on October 12, 2017, Nasdaq.com published: “Aerie Pharmaceuticals Inc. (AERI) Has Jumped To A New High On FDA News” on October 11, 2017. More interesting news about Aerie Pharmaceuticals Inc (NASDAQ:AERI) were released by: Seekingalpha.com and their article: “Aerie buys drug delivery technology from Envisia Therapeutics” published on October 05, 2017 as well as Nasdaq.com‘s news article titled: “Company Spotlight: Aerie Pharmaceuticals” with publication date: October 06, 2017.

Suffolk Capital Management Llc, which manages about $1.92 billion and $756.38M US Long portfolio, decreased its stake in Marvell Technology Group Ltd. (NASDAQ:MRVL) by 47,284 shares to 760,072 shares, valued at $12.56M in 2017Q2, according to the filing. It also reduced its holding in Morgan Stanley (NYSE:MS) by 147,422 shares in the quarter, leaving it with 76,148 shares, and cut its stake in Teligent Inc..

Among 34 analysts covering Microsoft Corporation (NASDAQ:MSFT), 28 have Buy rating, 2 Sell and 4 Hold. Therefore 82% are positive. Microsoft Corporation had 120 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, August 7, the company rating was maintained by Credit Suisse. BMO Capital Markets maintained Microsoft Corporation (NASDAQ:MSFT) rating on Wednesday, July 20. BMO Capital Markets has “Outperform” rating and $62 target. As per Friday, July 21, the company rating was maintained by Barclays Capital. BMO Capital Markets maintained it with “Buy” rating and $86.0 target in Wednesday, August 23 report. Morgan Stanley upgraded Microsoft Corporation (NASDAQ:MSFT) on Wednesday, January 13 to “Overweight” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, July 21 report. The rating was maintained by BMO Capital Markets with “Outperform” on Friday, January 27. UBS maintained Microsoft Corporation (NASDAQ:MSFT) rating on Friday, October 23. UBS has “Buy” rating and $56 target. Nomura maintained Microsoft Corporation (NASDAQ:MSFT) rating on Tuesday, April 19. Nomura has “Buy” rating and $36 target. The company was maintained on Thursday, June 1 by Canaccord Genuity.

Since May 1, 2017, it had 0 insider purchases, and 8 selling transactions for $1.04 billion activity. $1.81M worth of Microsoft Corporation (NASDAQ:MSFT) shares were sold by COURTOIS JEAN PHILIPPE. $481.95M worth of Microsoft Corporation (NASDAQ:MSFT) was sold by Morfit G Mason. GATES WILLIAM H III sold $207.65M worth of stock or 3.00 million shares.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Seekingalpha.com which released: “Microsoft Has The Best Competitive Advantage In Cloud” on September 26, 2017, also Investorplace.com with their article: “‘Boring’ Microsoft Corporation (MSFT) Stock Is Still a Must-Have” published on October 11, 2017, Seekingalpha.com published: “Microsoft: Azure fuels Dividend Growth” on October 07, 2017. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Seekingalpha.com and their article: “Microsoft ends new features, hardware for Windows 10 Mobile” published on October 09, 2017 as well as Investorplace.com‘s news article titled: “How Soon Will Microsoft Corporation (MSFT) Stock Hit a New Record $86?” with publication date: October 06, 2017.

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on October, 19. They expect $0.74 EPS, down 2.63% or $0.02 from last year’s $0.76 per share. MSFT’s profit will be $5.70 billion for 26.05 P/E if the $0.74 EPS becomes a reality. After $0.98 actual EPS reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -24.49% negative EPS growth.

Investors sentiment decreased to 0.82 in Q2 2017. Its down 0.02, from 0.84 in 2017Q1. It dropped, as 39 investors sold MSFT shares while 982 reduced holdings. 132 funds opened positions while 703 raised stakes. 5.53 billion shares or 0.72% more from 5.49 billion shares in 2017Q1 were reported. New England Mngmt Incorporated invested 0.92% in Microsoft Corporation (NASDAQ:MSFT). Lenox Wealth holds 3,672 shares. Cardinal Capital Management invested in 1.61% or 230,546 shares. Putnam Invests Lc reported 2.86% in Microsoft Corporation (NASDAQ:MSFT). Schulhoff holds 0.5% or 11,959 shares in its portfolio. Thompson Davis And, a Virginia-based fund reported 12,406 shares. Reinhart invested 0.05% in Microsoft Corporation (NASDAQ:MSFT). 813,906 are owned by Wedge Capital Mgmt L LP Nc. First Financial In invested 1.55% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Wedgewood Pa reported 19,495 shares stake. Moreover, Independent Port Consultants Inc has 0.43% invested in Microsoft Corporation (NASDAQ:MSFT) for 14,897 shares. North American Mgmt Corp reported 2.14% in Microsoft Corporation (NASDAQ:MSFT). Managed Asset Portfolios Ltd has 243,024 shares. Tetrem Capital Mngmt holds 3.64% in Microsoft Corporation (NASDAQ:MSFT) or 1.21M shares. Jupiter Asset Mgmt Ltd accumulated 0.54% or 224,566 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts